• 1. Aggregation of the metallocycles {Cu8} and {Cu20} using [Cu(bp)] units (H2bp = bis(2-hydroxybenzyl)amine): structures and magnetic properties?
  Mei-Yu Xu,Ya-Ting Wang,Qing-Ling Ni,Zi-Hao Zhang,Guang-Ming Liang,Liu-Cheng Gui Dalton Trans., 2016,45, 4993-4997
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An automated in-chip-catalytic–spectrophotometric method for determination of copper(ii) using a multisyringe flow injection analysis-multipumping flow system?
  Camelia Henríquez,Edwin Palacio,Víctor Cerdà Anal. Methods, 2014,6, 8494-8504

Introduction to (3R,4R)-4-(2-methylpropyl)pyrrolidine-3-carboxylic acid hydrochloride (CAS No. 641634-69-7)

The compound (3R,4R)-4-(2-methylpropyl)pyrrolidine-3-carboxylic acid hydrochloride (CAS No. 641634-69-7) is a highly specialized organic compound with significant applications in the fields of pharmaceuticals and biotechnology. This compound belongs to the class of pyrrolidine derivatives, which are known for their unique chemical properties and biological activities. The pyrrolidine ring serves as a versatile scaffold for various functional groups, making this compound a valuable tool in drug discovery and development.

Recent studies have highlighted the potential of (3R,4R)-4-(2-methylpropyl)pyrrolidine-3-carboxylic acid hydrochloride in modulating cellular signaling pathways. Researchers have demonstrated that this compound exhibits selective binding to specific receptors, making it a promising candidate for the treatment of neurological disorders such as Alzheimer's disease and Parkinson's disease. The hydrochloride salt form of this compound enhances its solubility and bioavailability, which are critical factors in drug delivery systems.

The synthesis of (3R,4R)-4-(2-methylpropyl)pyrrolidine-3-carboxylic acid hydrochloride involves a multi-step process that combines organic synthesis techniques with stereochemical control. The use of chiral catalysts ensures the formation of the desired enantiomer, which is crucial for maintaining the compound's biological activity. This approach not only improves the efficiency of the synthesis but also minimizes environmental impact by reducing waste generation.

In terms of applications, this compound has shown remarkable potential in the development of neuroprotective agents. Experimental data from preclinical studies suggest that it can effectively reduce oxidative stress and inflammation in neuronal cells, thereby protecting them from degeneration. Furthermore, its ability to cross the blood-brain barrier makes it an ideal candidate for targeting central nervous system disorders.

Another area where (3R,4R)-4-(2-methylpropyl)pyrrolidine-3-carboxylic acid hydrochloride has garnered attention is in the field of enzyme inhibition. Studies have revealed its inhibitory effects on key enzymes involved in metabolic pathways, offering new possibilities for treating metabolic disorders such as diabetes and obesity. The compound's selectivity towards specific enzyme targets ensures minimal off-target effects, which is a critical consideration in drug design.

From a structural perspective, the pyrrolidine ring provides a rigid framework that facilitates interactions with biological macromolecules. The presence of the 2-methylpropyl group introduces steric hindrance, which can influence the compound's binding affinity and selectivity. Additionally, the carboxylic acid group plays a pivotal role in forming hydrogen bonds with target molecules, further enhancing its biological activity.

The development of (3R,4R)-4-(2-methylpropyl)pyrrolidine-3-carboxylic acid hydrochloride has been driven by advancements in stereochemistry and medicinal chemistry. These disciplines have enabled scientists to design compounds with precise three-dimensional structures that maximize therapeutic efficacy while minimizing adverse effects. The integration of computational modeling techniques has further accelerated the discovery process by predicting the compound's behavior in vivo.

In conclusion, (3R,4R)-4-(2-methylpropyl)pyrrolidine-3-carboxylic acid hydrochloride (CAS No. 641634-69-7) represents a cutting-edge advancement in organic chemistry with broad implications for medicine and biotechnology. Its unique structure, combined with its potent biological activity, positions it as a key player in the development of novel therapeutic agents for treating complex diseases.

• 261896-39-3((3R,4R)-4-Isobutylpyrrolidine-3-carboxylic acid)
• 1049980-59-7((3S,4S)-4-Isopropylpyrrolidine-3-carboxylicacid)
• 1049740-49-9((±)-trans-4-Isopropylpyrrolidine-3-carboxylic Acid Hydrochloride)
• 953079-94-2(Pyrrolidine-3-carboxylic acid hydrochloride)
• 1202245-51-9((3R)-pyrrolidine-3-carboxylic acid;hydrochloride)
• 261896-36-0((3R,4R)-rel-4-Isopropylpyrrolidine-3-carboxylic acid)
• 261896-37-1(3-Pyrrolidinecarboxylicacid,4-propyl-,(3R,4R)-rel-(9CI))
• 1330750-36-1((+/-)-Trans-4-Isopropylpyrrolidine-3-carboxylic Acid Hydrochloride)
• 261896-40-6((3S,4S)-4-Isobutylpyrrolidine-3-carboxylicacid)
• 1124369-40-9((3S)-pyrrolidine-3-carboxylic acid hydrochloride)